相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pericardial Involvement in Cancer
Johnny Chahine et al.
AMERICAN JOURNAL OF CARDIOLOGY (2021)
Pericardial effusion after definitive concurrent chemotherapy and intensity modulated radiotherapy for esophageal cancer
Tzu-Hui Pao et al.
RADIATION ONCOLOGY (2020)
Can we safely reduce the radiation dose to the heart while compromising the dose to the lungs in oesophageal cancer patients?
Jannet C. Beukema et al.
RADIOTHERAPY AND ONCOLOGY (2020)
Radiation-Associated Pericardial Disease
Natalie Szpakowski et al.
CURRENT CARDIOLOGY REPORTS (2019)
Cardiac dose is associated with immunosuppression and poor survival in locally advanced non-small cell lung cancer
Jessika A. Contreras et al.
RADIOTHERAPY AND ONCOLOGY (2018)
Incidence and Predictors of Pericardial Effusion After Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer
Matthew S. Ning et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
Validation and Modification of a Prediction Model for Acute Cardiac Events in Patients With Breast Cancer Treated With Radiotherapy Based on Three-Dimensional Dose Distributions to Cardiac Substructures
Veerle A. B. van den Bogaard et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Cardiac Toxicity After Radiotherapy for Stage III Non-Small-Cell Lung Cancer: Pooled Analysis of Dose-Escalation Trials Delivering 70 to 90 Gy
Kyle Wang et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
Karel G. M. Moons et al.
ANNALS OF INTERNAL MEDICINE (2015)
Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study
Jeffrey D. Bradley et al.
LANCET ONCOLOGY (2015)
Symptomatic Pericardial Effusion After Chemoradiation Therapy in Esophageal Cancer Patients
Junichi Fukada et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer
Sarah C. Darby et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Pericardial and Pleural Effusions after Definitive Radiotherapy for Esophageal Cancer
Junichi Fukada et al.
JOURNAL OF RADIATION RESEARCH (2012)
PHASE II STUDY OF CHEMORADIOTHERAPY WITH 5-FLUOROURACIL AND CISPLATIN FOR STAGE II-III ESOPHAGEAL SQUAMOUS CELL CARCINOMA: JCOG TRIAL (JCOG 9906)
Ken Kato et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
DEVELOPMENT AND VALIDATION OF A HEART ATLAS TO STUDY CARDIAC EXPOSURE TO RADIATION FOLLOWING TREATMENT FOR BREAST CANCER
Mary Feng et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
RADIATION-INDUCED CARDIAC TOXICITY AFTER THERAPY FOR BREAST CANCER: INTERACTION BETWEEN TREATMENT ERA AND FOLLOW-UP DURATION
Senem Demirci et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
Risk factors for pericardial effusion in inoperable esophageal cancer patients treated with definitive chemoradiation therapy
Xiong Wei et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Lyman-Kutcher-Burman NTCP model parameters for radiation pneumonitis and xerostomia based on combined analysis of published clinical data
V. A. Semenenko et al.
PHYSICS IN MEDICINE AND BIOLOGY (2008)
Mortality from cardiovascular disease more than 10 years after radiotherapy for breast cancer: nationwide cohort study of 90 000 Swedish women
S Darby et al.
BRITISH MEDICAL JOURNAL (2003)
Radiation-associated cardiovascular disease
MJ Adams et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2003)
Analysis of radiation-induced liver disease using the Lyman NTCP model
LA Dawson et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2002)
分享论文
